RxDoctor Payments Data

Gregory Artz, MD

Otolaryngology · Wyoming, MINPI 1962626671

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Medtronic at 36.3% of the total. Reporting peaked in 2024 at $1,466 and has fallen 85.9% since, to $206 in 2025.

$4,966in general payments, 2019–2025

Across 70 payments — averaging $70.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Intersect ENT, Inc.$2K
  • Advanced Bionics, LLC$381
  • Stryker$246
  • Acclarent, Inc$240
  • Cochlear Americas$196
  • plus $592 from 9 others

What the payments were for

  • Food & beverage$4,966100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,966 in reported general payments places this provider in the 80th percentile of 257 otolaryngology providers in Michigan.

See all otolaryngology providers in Michigan

Medicare billing

Part B allowed, 2024
$72,124
Medicare patients
203
Services billed
966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TobradexTobramycin/Dexamethasone12$12,661
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth64$7,575
Ipratropium Bromide80$2,087
Fluticasone Propionate81$901
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort11$569
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen72$357
Nortriptyline Hcl16$337
Ofloxacin11$242
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid18$216
RizatriptanRizatriptan Benzoate18$129
Diazepam33$101
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav11$95
Methylprednisolone12$72
Cephalexin36$66
Prednisone12$32

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Wyoming

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →